Market Place
Sourcing Support
Marksans Pharma Q1 FY25 revenue up 18%
14 Aug 2024 //
INDIANPHARMAPOST
UK Relonchem receives marketing authorization for Levonorgestrel 1.5 mg Tablets
06 Aug 2024 //
#N/A
Marksans declines after US FDA issues Form 483 with 5 observations to Goan plant
18 Apr 2024 //
BUSINESS STANDARD
Marksans Q3 FY24 revenue up 22% at Rs 586 Cr
15 Feb 2024 //
INDIAN PHARMA POST
Marksans receives USFDA approval for Guaifenesin Extended-Release Tablets
23 Aug 2023 //
INDIAN PHARMA POST
Marksans`s Generic Guaifenesin Receives Approval in the U.S.
21 Aug 2023 //
FDA
Marksans`s Generic Acetaminophen, Ibuprofen Receives Approval in the U.S.
10 Jul 2023 //
FDA
Marksans Pharma gets final USFDA nod for generic version of Famotidine tablets
10 Mar 2023 //
ECONOMIC TIMES
Marksans` Generic Famotidine Receives Approval in the U.S.
08 Mar 2023 //
FDA
Marksans Pharma announces UK MHRA approval for Fluoxetine 20mg/5ml Oral Solution
24 Jan 2023 //
INDIAN PHARMA POST
Marksans acquires capacity from Tevapharm India
12 Oct 2022 //
EXPRESS PHARMA
Marksans Pharma acquires Teva`s manufacturing site in Goa
12 Oct 2022 //
ECONOMIC TIMES
Marksans Pharma Generic Pregabalin Receives Approval in the U.S.
18 Jul 2022 //
FDA
Marksans Pharma gets UK MHRA nod for diarrhoea medication
10 Dec 2021 //
EXPRESS PHARMA
Marksans Pharma gets US FDA approval for tylenol ER tablets
27 Aug 2021 //
PHARMABIZ
Marksans Pharma Q1 net profit rises 27% at Rs. 62.6 crore
11 Aug 2021 //
PHARMABIZ
Indian drug firms recall various products in US market
13 Nov 2020 //
TRIBUNEINDIA
Marksans Pharma freezes at upper circuit on Metformin hcl tablets recall
05 Oct 2020 //
INDIAN INFOLINE
Marksans Pharma confident of achieving good growth for FY21
11 Sep 2020 //
PHARMABIZ
Metformin recalls continue as Bayshore pulls diabetes drug on carcinogen scare
21 Aug 2020 //
FIERCEPHARMA
Indian drug firms recall products in US market
06 Jul 2020 //
ECONOMICTIMES
FDA names five companies recalling NDMA-contaminated metformin
15 Jun 2020 //
RAPS
Marksans Pharma gets EIR from USFDA for New York unit
11 Feb 2020 //
BUSINESSWIRE
Marksans Pharma gets EIR from USFDA for New York unit
11 Feb 2020 //
BUSINESSWIRE
Marksans Pharma rallies 5% after Goa unit receives EIR from USFDA
06 Jun 2019 //
MONEYCONTROL
Buy Marksans Pharma; target of Rs 55: Centrum
22 Feb 2018 //
MONEYCONTROL
Enforcement Report - Week of January 31, 2018
31 Jan 2018 //
FDA
Marksans Pharma gets EIR from USFDA for its Goa facility
09 Oct 2017 //
ECONOMIC TIMES
Enforcement Report - Week of August 9, 2017
09 Aug 2017 //
FDA
FDA Issues Form 483 to Marksans Pharma Ltd.
25 Apr 2017 //
FDA
Marksans Pharma’s Generic Dutasteride Receives Approval In US
12 Apr 2017 //
FDA
Marksans Pharma gains 9% on heavy volumes
11 Apr 2017 //
BUSINESS-STANDARD
Marksans Pharma soars as UK MHRA finds no critical observations at Goa unit
20 Feb 2017 //
BUSSINESS STANDARD
US FDA actions, DPCO hit sales & profits of top 30 cos in first half of 2016-17
21 Nov 2016 //
PHARMABIZ
Marksans Pharma gets US FDA nod for Paricalcitol drug
18 Oct 2016 //
EXPRESS PHARMA
Marksans Pharma Surges On USFDA Nod For Generic Loratadine
26 Sep 2016 //
FDA
Marksans Pharma gets USFDA nod for diabetes treatment tablets
02 May 2016 //
ECONOMIC TIMES
Tesco and Waitrose supplier Marksans banned from shipping non-critical meds
21 Mar 2016 //
IN PHARMATECHNOLOGIST
Marksans Pharma Limited fails EDQM Inspection
17 Mar 2016 //
EDQM
Marksans Pharma Goa plant comes under UK regulator scanner
14 Jan 2016 //
BUSINESS TODAY
Marksans Pharma gains on acquisition of US-based company
29 Jun 2015 //
BUSINESS STANDARD
U.K. regulators find issues with Indian-owned API distributor Relonchem
06 May 2015 //
FIERCE PHARMA MANUFACTURING
